Browsing Tag

ANG-3070

Angion to Present Multiple Posters at Kidney Week 2021

Jason Junior Oct 19, 2021

UNIONDALE, N.Y., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Angion Biomedica Corp (NASDAQ:ANGN), a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address…

Health

Angion Reports Positive Results from Phase 1 Healthy Volunteer Study for ANG-3070 and FDA…

Jason Junior Aug 3, 2021

ANG-3070 was well-tolerated across dose cohorts, achieving drug exposures in humans exceeding exposures in which activity was demonstrated in animal models of proteinuric kidney diseasesPharmacokinetic data potentially supportive of…